Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 14.2

Recipient Recurrence of Pretransplant Malignancies, 2000 to 2009

by Transplant Type

Organ Type Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total Total Recipients 23,281 24,260 24,921 25,486 27,053 28,117 28,942 28,372 27,966 28,465
# With Pre-Tx Malignancy (1) 874 1,004 1,202 1,211 1,302 1,437 1,628 1,739 1,892 2,046
# With Recurrence of Pre-Tx Malignancy (2) 58 67 80 73 60 75 70 64 76 36
% With Recurrence of Pre-Tx Malignancy (3) 6.6% 6.7% 6.7% 6.0% 4.6% 5.2% 4.3% 3.7% 4.0% 1.8%
# With Recurrence, but no Pre-Tx Malignancy (4) 51 84 96 106 122 150 147 104 75 47
Heart-Lung Total Recipients 48 27 33 29 40 35 31 31 27 29
# With Pre-Tx Malignancy (1) 1 2 1 3 1 1 - 1 4 -
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - - - - -
Heart Total Recipients 2,199 2,202 2,155 2,057 2,015 2,125 2,193 2,209 2,163 2,212
# With Pre-Tx Malignancy (1) 70 98 72 78 95 103 107 105 132 152
# With Recurrence of Pre-Tx Malignancy (2) 2 4 - 3 3 3 4 4 6 -
% With Recurrence of Pre-Tx Malignancy (3) 2.9% 4.1% - 3.8% 3.2% 2.9% 3.7% 3.8% 4.5% -
# With Recurrence, but no Pre-Tx Malignancy (4) 4 3 4 5 3 3 2 2 1 -
Intestine Total Recipients 82 113 107 116 152 178 175 198 185 180
# With Pre-Tx Malignancy (1) 4 4 3 6 9 2 5 9 10 11
# With Recurrence of Pre-Tx Malignancy (2) 1 1 - 1 - - - - 1 -
% With Recurrence of Pre-Tx Malignancy (3) 25.0% 25.0% - 16.7% - - - - 10.0% -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - 1 - - - 1 1 2
Kidney Total Recipients 13,620 14,276 14,779 15,137 16,006 16,483 17,095 16,634 16,521 16,830
# With Pre-Tx Malignancy (1) 348 424 458 462 513 660 748 763 834 884
# With Recurrence of Pre-Tx Malignancy (2) 13 13 11 13 13 18 12 12 12 7
% With Recurrence of Pre-Tx Malignancy (3) 3.7% 3.1% 2.4% 2.8% 2.5% 2.7% 1.6% 1.6% 1.4% 0.8%
# With Recurrence, but no Pre-Tx Malignancy (4) 17 23 19 22 14 14 17 8 4 8
Kidney-Pancreas Total Recipients 915 891 906 871 881 903 924 864 837 854
# With Pre-Tx Malignancy (1) 8 13 9 9 9 13 18 10 10 12
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) 1 1 1 2 - - - - - -
Liver Total Recipients 5,001 5,195 5,332 5,673 6,171 6,444 6,651 6,494 6,319 6,320
# With Pre-Tx Malignancy (1) 402 414 611 610 623 583 647 751 785 870
# With Recurrence of Pre-Tx Malignancy (2) 38 47 68 56 43 53 53 46 55 29
% With Recurrence of Pre-Tx Malignancy (3) 9.5% 11.4% 11.1% 9.2% 6.9% 9.1% 8.2% 6.1% 7.0% 3.3%
# With Recurrence, but no Pre-Tx Malignancy (4) 27 53 70 74 103 129 124 87 67 34
Lung Total Recipients 977 1,083 1,054 1,099 1,185 1,407 1,406 1,471 1,478 1,661
# With Pre-Tx Malignancy (1) 28 34 35 34 37 60 90 82 106 108
# With Recurrence of Pre-Tx Malignancy (2) 3 1 1 - 1 1 1 2 1 -
% With Recurrence of Pre-Tx Malignancy (3) 10.7% 2.9% 2.9% - 2.7% 1.7% 1.1% 2.4% 0.9% -
# With Recurrence, but no Pre-Tx Malignancy (4) 2 4 2 1 2 3 4 3 1 1
Pancreas After Kidney Total Recipients 305 305 375 344 420 343 293 261 213 198
# With Pre-Tx Malignancy (1) 8 8 8 5 10 8 9 10 3 7
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - - 1 - -
Pancreas Transplant Alone Total Recipients 134 168 180 160 183 199 174 210 223 181
# With Pre-Tx Malignancy (1) 5 7 5 4 5 7 4 8 8 2
# With Recurrence of Pre-Tx Malignancy (2) 1 1 - - - - - - 1 -
% With Recurrence of Pre-Tx Malignancy (3) 20.0% 14.3% - - - - - - 12.5% -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - 1 - 1 - 2 1 2


Source: OPTN/SRTR Data as of October 1, 2010.

(-) = None in category.

Includes both deceased and living donor transplants.

(1) Pre-Tx malignancy reported on the TCR or TRR Form.

(2) Recurrence reported on the Transplant Recipient Follow-up Form.

(3) Percent recurrence is calculated based on total with reported pre-tx malignancy.

(4) Recurrence reported on the follow-up form, but no pre-tx malignancy reported, so these are not included in recurrence rates.

Recipient malignancy statistics are based on voluntary reporting to the OPTN